Randomised intravenous iron trials for heart failure: an individual-patient-data meta-analysis

30 August 2026 (16:15 - 16:30)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail

Effect of In-Hospital Initiation of Dapagliflozin on Decongestion-Related Endpoints in Acute Heart Failure: A Prespecified Analysis of the DAPA ACT HF-TIMI 68 Trial

Doctor A. Small (Boston, US)

Presentation thumbnail

Obesity, Frail Obesity, and Clinical Outcomes with a Fully Magnetically Levitated Left Ventricular Assist Device: the MOMENTUM 3 Trial

Doctor M. Vukicevic (Belgrade, RS)

Presentation thumbnail

Evolving Trends in Treatments, Morbidity, and Mortality in Heart Failure: 30 Years of Data from the Italian Network of Heart Failure (IN-HF) Registry

Doctor A. Maggioni (Florence, IT)

Access the full session

Session thumbnail

Late-Breaking Clinical Science: optimising outcomes in heart failure

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET

You may be interested in

Congress Presentation

IV iron should routinely be considered in heart failure: pro

11 May 2026

Congress Presentation

Effects of FCM on recurrent HF hospitalizations: an individual participant data meta-analysis

26 August 2023

Congress Presentation

Associations of different definitions of iron deficiency with cardiac structure and function, congestion, exercise capacity and prognosis in heart failure

31 August 2024

Congress Presentation

FAIR-HF2 DZHK05: Efficacy of ferric carboxymaltose in heart failure and iron deficiency stratified by transferrin saturation

17 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources